| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.084 | 0.08 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |